MURINE CYTOTOXIC T-CELL RESPONSE SPECIFIC FOR HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-B (GB) INDUCED BY ADENOVIRUS AND VACCINIA VIRUS RECOMBINANTS EXPRESSING GB

被引:28
作者
BERENCSI, K
RANDO, RF
DETAISNE, C
PAOLETTI, E
PLOTKIN, SA
GONCZOL, E
机构
[1] NIDR,BETHESDA,MD 20892
[2] INST PASTEUR,69280 MARCY LETOILE,FRANCE
[3] VIROGENET CORP,TROY,NY 12180
关键词
D O I
10.1099/0022-1317-74-11-2507
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A murine model of the cytotoxic T lymphocyte (CTL) response to glycoprotein B (gB) of human cytomegalovirus (HCMV) was developed based on the use of adenovirus (Ad) and vaccinia virus (Vac) recombinants expressing gB. Mice of different major histocompatibility haplotypes [CBA (H-2k), BALB/k (H-2k) and BALB/c (H-2d)] infected with the Ad-gB recombinant developed an Ad-specific CTL response. However, only the H-2k mice developed a significant HCMV gB-specific CTL response, as indicated by the major histocompatibility complex class I-restricted lysis of Vac strain Copenhagen (VacC)-gB recombinant-infected target cells by H-2k mouse immune spleen cells. The VacC-gB recombinant elicited only a weak gB-specific CTL response in these mice, indicating that the observed gB-specific CTL response in mice is dependent on the expression vector used for immunization. The gB-specific cytotoxicity observed in H-2k mice was mediated by the CD8 lymphocyte subset.
引用
收藏
页码:2507 / 2512
页数:6
相关论文
共 27 条
  • [1] MECHANISMS INFLUENCING THE IMMUNODOMINANCE OF T-CELL DETERMINANTS
    ADORINI, L
    APPELLA, E
    DORIA, G
    NAGY, ZA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) : 2091 - 2104
  • [2] BAKAY M, 1992, ACTA VIROL, V36, P269
  • [3] BERENCSI K, 1991, 3RD INT CYT WORKSH, P191
  • [4] HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC T-CELLS - RELATIVE FREQUENCY OF STAGE-SPECIFIC CTL RECOGNIZING THE 72-KD IMMEDIATE EARLY PROTEIN AND GLYCOPROTEIN-B EXPRESSED BY RECOMBINANT VACCINIA VIRUSES
    BORYSIEWICZ, LK
    HICKLING, JK
    GRAHAM, S
    SINCLAIR, J
    CRANAGE, MP
    SMITH, GL
    SISSONS, JGP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) : 919 - 931
  • [5] INDUCTION OF COMPLEMENT-DEPENDENT AND COMPLEMENT-INDEPENDENT NEUTRALIZING ANTIBODIES BY RECOMBINANT-DERIVED HUMAN CYTOMEGALO-VIRUS GP55-116 (GB)
    BRITT, WJ
    VUGLER, L
    STEPHENS, EB
    [J]. JOURNAL OF VIROLOGY, 1988, 62 (09) : 3309 - 3318
  • [6] CELL-SURFACE EXPRESSION OF HUMAN CYTOMEGALOVIRUS (HCMV) GP55-116 (GB) - USE OF HCMV-RECOMBINANT VACCINIA VIRUS-INFECTED CELLS IN ANALYSIS OF THE HUMAN NEUTRALIZING ANTIBODY-RESPONSE
    BRITT, WJ
    VUGLER, L
    BUTFILOSKI, EJ
    STEPHENS, EB
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (03) : 1079 - 1085
  • [7] A COMPLEX BETWEEN THE MHC CLASS-I HOMOLOG ENCODED BY HUMAN CYTOMEGALOVIRUS AND BETA-2 MICROGLOBULIN
    BROWNE, H
    SMITH, G
    BECK, S
    MINSON, T
    [J]. NATURE, 1990, 347 (6295) : 770 - 772
  • [8] TEMPORAL REGULATION OF INFLUENZA HEMAGGLUTININ EXPRESSION IN VACCINIA VIRUS RECOMBINANTS AND EFFECTS ON THE IMMUNE-RESPONSE
    COUPAR, BEH
    ANDREW, ME
    BOTH, GW
    BOYLE, DB
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (12) : 1479 - 1487
  • [9] IDENTIFICATION OF THE HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-B GENE AND INDUCTION OF NEUTRALIZING ANTIBODIES VIA ITS EXPRESSION IN RECOMBINANT VACCINIA VIRUS
    CRANAGE, MP
    KOUZARIDES, T
    BANKIER, AT
    SATCHWELL, S
    WESTON, K
    TOMLINSON, P
    BARRELL, B
    HART, H
    BELL, SE
    MINSON, AC
    SMITH, GL
    [J]. EMBO JOURNAL, 1986, 5 (11) : 3057 - 3063
  • [10] PROTECTION AGAINST LETHAL CYTOMEGALOVIRUS-INFECTION BY A RECOMBINANT VACCINE CONTAINING A SINGLE NONAMERIC T-CELL EPITOPE
    DELVAL, M
    SCHLICHT, HJ
    VOLKMER, H
    MESSERLE, M
    REDDEHASE, MJ
    KOSZINOWSKI, UH
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (07) : 3641 - 3646